FDA Clearance Tracker · K231804
PRIME-XV FreezIS DMSO-Free MD
Last checked: Nov 20, 2026Latest source record: Nov 9, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Nov 9, 2023
Substantially Equivalent
Time to decision
142 days
Received Jun 20, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Abbreviated
Device class
Class II
The decision
- FDA number
- K231804
- Device name
- PRIME-XV FreezIS DMSO-Free MD
- Applicant
- Fujifilm Irvine Scientific
- Applicant location
- Santa Ana, CA
- Received
- Jun 20, 2023
- Decided
- Nov 9, 2023
- Decision
- Substantially Equivalent
- Submission type
- Abbreviated
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.5885
- Specialty
- GI, Urology & Nephrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NDS. The earliest in FDA's data is DEN000008, decided Feb 16, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K231804
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Fujifilm Irvine Scientific
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Fast Warm - NX510(k)
K250445 · Decided Sep 12, 2025 · 210 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
K241341 · Decided Sep 26, 2024 · 136 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
K233764 · Decided Apr 24, 2024 · 152 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.